Top Stock Movers Today | Top Stock Gainers & Top Stock Losers

Stock Movers

Gainers

TickerCompany±%Buy Stock
Loading...
Get in real-time

Loser

TickerCompany±%Buy Stock
Loading...
Get in real-time

Stock Movers

Gainers

TickerCompany±%Buy Stock
EBSEmergent BioSolutions$3.2769.68%3MBuy/Sell
XBPXBP Europe Holdings$2.1967.17%29.5KBuy/Sell
VWEVintage Wine Estates$0.3966.85%204.3KBuy/Sell
NUWENuwellis$0.2158.64%1.4MBuy/Sell
ASPNAspen Aerogels$23.7255.84%992.6KBuy/Sell
ENVXEnovix$9.4545.15%4.6MBuy/Sell
SGBXSafe & Green Holdings$3.0036.11%155.7KBuy/Sell
MINFT$4.1433.98%20.8KBuy/Sell
CVNACarvana$116.5133.78%6.3MBuy/Sell
SNSESensei Biotherapeutics$1.6833.33%80.6KBuy/Sell
PRDOPerdoceo Education$24.0931.35%556.3KBuy/Sell
JAGXJaguar Health$0.2930.71%62.6MBuy/Sell
MCAGRMountain Crest Acquisition Corp. V - Right$0.1330.66%6KBuy/Sell
NXTTNext Technology Holding$4.8029.55%42.9KBuy/Sell
HAOHaoxi Health Technology$9.1029.26%37.7KBuy/Sell
OPIOffice Props IT$2.5628.24%1.2MBuy/Sell
CNTXContext Therapeutics$1.7427.94%56.3KBuy/Sell
CZOOCazoo Gr$10.6126.85%1.9MBuy/Sell
OBIOOrchestra BioMed Hldgs$5.5626.36%46.7KBuy/Sell
GCIGannett Co$3.0426.34%741KBuy/Sell
Get in real-time

Loser

TickerCompany±%Buy Stock
VSTSVestis$10.50-43.14%1.7MBuy/Sell
XPELXPEL$32.94-38.77%138.3KBuy/Sell
PLTNPlutonian Acquisition$6.17-32.57%34.5KBuy/Sell
FSLYFastly$8.74-32.37%4.3MBuy/Sell
BONBon Natural Life$2.72-29.33%26KBuy/Sell
ARAYAccuray$1.53-29.27%495.1KBuy/Sell
GRDIGRIID Infrastructure$0.65-27.45%728.1KBuy/Sell
HSDTHelius Medical Tech$2.64-26.54%407.3KBuy/Sell
PEVPhoenix Motor$0.41-26.21%52.3KBuy/Sell
ASNSActelis Networks$0.60-24.55%13.1KBuy/Sell
HRTGHeritage Insurance Hldgs$7.96-22.7%407.6KBuy/Sell
NTGRNetgear$11.71-21.62%216.8KBuy/Sell
IFNrIndia Fund, Inc. (The) Rights (expiring May 14, 2024) Rights$0.06-20.92%786.1KBuy/Sell
WEAVWeave Communications$8.65-20.87%400.2KBuy/Sell
RHEpARegional Health Properties, Inc. 10.875% Series A Cumulative Redeemable Preferred Stock$0.54-20.44%0.7KBuy/Sell
NIVFNewGenIvf Group$1.27-20.38%15.2MBuy/Sell
DRVNDriven Brands Hldgs$11.70-20.23%1.1MBuy/Sell
FRSHFreshworks$14.71-19.4%2.6MBuy/Sell
ROOTRoot$56.66-18.96%856.8KBuy/Sell
IMCCIM Cannabis$0.90-18.91%1.4MBuy/Sell
Get in real-time
Session: May 1, 2024 4:00PM EDT - May 2, 2024 3:59PM EDT

Stock News of the Day

Best Stock Promotion Right Now

Webull Promotion!
Webull Promotion!
Make a deposit of $100 or more into your account, maintain your funds to get 60 FREE fractional shares! Each share is valued between $3 - $3000!
Disclosure: All investments involve risk, and there is always the possibility that you may lose money when you invest in securities or other financial products. The value of a given security may increase or decrease, and investors may lose money, including their original investment. You should consider your investment objectives carefully before investing. Webull Financial LLC, member FINRA & SIPC. Regulatory and Exchange Fees may apply.

Best Online Stock Brokers

Claim Exclusive Offers

Apple Q2 Earnings Beat Muted Forecast On Services, Mac Strength: Installed Base At Fresh Record, Cupertino Announces Massive $110B Buyback (UPDATED)
Cloudflare Stock Tanks Following Q1 Results, Subpar Guidance - Here's Why
Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?
Cloudflare Stock Tanks Following Q1 Results, Subpar Guidance - Here's Why
Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?
Booking.Com's Q1 Earnings Show Growth In Travel Demand - Here's Why
Block Stock Soars On Q1 Earnings, Strategic Bitcoin Investment: Details

Best Online Stock Brokers

Claim Exclusive Offers

Movers Recent News

Sony, Apollo Make $26B Offer For Paramount: Report
Paramount Global shares are trading higher Thursday following a report that Sony Group and Apollo Management have submitted a $26 billion, all-cash offer for the company.
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation
Regeneron Pharmaceuticals Q1 2024 earnings: EPS down 5%, sales miss; Eylea US sales drop 16%, Dupixent offsets. Oncology treatment Libtayo sales surge 49%.
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%.
What's Going On With XPeng Stock?
XPeng delivered 9,393 EVs in April, representing a 33% increase year-over-year, up 4% over the prior month. The company highlighted 1,959 X9 vehicles in April, with cumulative deliveries nearing 10,000 units since its launch. Year-to-date, XPeng has delivered 31,214 EVs, a 23% increase year-over-year.
Peloton Stock Falls After Worse-Than-Expected Q3 Results, New Co-CEOs, Restructuring Plan
Peloton announced a restructuring program to include a reduction to its global headcount by approximately 15%, impacting roughly 400 Peloton team members. The company will also continue reducing its retail footprint and redesign its international go-to-market approach to be more targeted and efficient. 
Rivian Automotive Receives $827M Incentive Package: What's Going On With Rivian Stock?
Rivian has received an $827 million incentive package from the State of Illinois Department of Commerce & Economic Opportunity, which will allow the company to expand operations at its plant in Normal, IL. The company said the funds from the incentive package will go towards expansion of the plant, improvements in public infrastructure and job training programs for Rivian's workforce. 
Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'
Pfizer analysts from Goldman see a positive outlook on Padcev, Prevnar, and Vindaqel, but Nurtec and Oxbryta execution needs work.
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a reported basis.
Why Bausch Health Companies Shares Are Falling After Q1 Results
Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%.
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains.
Why Plug Power Shares Are Surging Thursday
Plug Power shares are trading higher on Thursday. The company said it received contracts to supply cryogenic equipment to a multinational industrial gas company and a statewide electric utility company. 
What's Going On With Zimmer Biomet Shares After Q1 Earnings?
Zimmer Biomet beats Q1 earnings and sales estimates, with adjusted EPS at $1.94 and quarterly sales hitting $1.889 billion, prompting a slight dip in shares.
Thomson Reuters Triumphs in Q1 Backed by AI Product Roadmap and Strategic Acquisitions
Thomson Reuters Corp reported Q1 2024 revenue growth of 8%, beating analyst consensus, with adjusted EPS of $1.11. The stock gained, driven by 9% organic revenue growth. CEO is confident in their AI product roadmap. Outlook is $7.24-$7.27 billion. Stock up 17% in last 12 months.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers